This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BioProcess International
Delivered as a Hybrid Event
September 27-30, 2022Boston Convention and Exhibition Center

Vaibhav Deokar
Principal Scientist, Formulation Development at Lupin Limited


Mr. Vaibhav Deokar is Principal Scientist at R&D, Lupin Limited (Biotech Division), India. He has pursued M.Tech (Bioprocess Technology) from Institute of Chemical Technology (ICT), Mumbai and is pursuing PhD under the Lupin’s ASCENT PhD programme. He has authored research articles in peer reviewed journals and is key contributor to 6 formulation patents for biopharmaceuticals. He has 13+ years of experience in developing formulations, devices and technology transfer operations for fill-finish process of complex biopharmaceuticals like peptides, fusion proteins, monoclonal antibodies at drug product manufacturing sites. He has special interests in new product development, product differentiation and enhancement strategies and has provided new differentiation strategies for couple of products in pipeline.

Agenda Sessions

  • Strategies in Development and Manufacturing of Low Viscosity, Ultra-High Concentration Formulation for IgG1 Antibody